Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2021

Feb 3, 2021

30681_dirs_2021-02-03_2b48d7eb-c54c-40cb-9e9f-2e378df5a117.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2020-12-31

Reporting Person: BAKER G LEONARD JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-01 Common Stock G 0.0000 $0.0000 Disposed 3114793.0000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 996838.0000 Direct
Common Stock 955055.0000 Indirect

Footnotes

F1: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.